Don Husereau

13.5k total citations · 11 hit papers
110 papers, 9.2k citations indexed

About

Don Husereau is a scholar working on Economics and Econometrics, General Health Professions and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Don Husereau has authored 110 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Economics and Econometrics, 49 papers in General Health Professions and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Don Husereau's work include Health Systems, Economic Evaluations, Quality of Life (80 papers), Healthcare cost, quality, practices (38 papers) and Healthcare Policy and Management (34 papers). Don Husereau is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (80 papers), Healthcare cost, quality, practices (38 papers) and Healthcare Policy and Management (34 papers). Don Husereau collaborates with scholars based in Canada, United Kingdom and United States. Don Husereau's co-authors include Federico Augustovski, Josephine Mauskopf, Dan Greenberg, Elizabeth Loder, Andrew Briggs, Chris Carswell, Stavros Petrou, Michael Drummond, David Moher and Lisa Caulley and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Don Husereau

106 papers receiving 9.0k citations

Hit Papers

Consolidated Health Economic Evaluation Reporting Standar... 2012 2026 2016 2021 2013 2013 2012 2022 2013 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Don Husereau Canada 34 3.1k 1.7k 1.3k 1.2k 1.0k 110 9.2k
Federico Augustovski Argentina 39 3.6k 1.2× 2.0k 1.2× 1.4k 1.0× 1.5k 1.3× 1.2k 1.1× 180 10.3k
Chris Carswell United States 24 2.3k 0.8× 1.2k 0.7× 1.1k 0.8× 1.0k 0.9× 783 0.7× 49 7.1k
C. Daniel Mullins United States 48 3.1k 1.0× 2.2k 1.3× 1.3k 1.0× 1.2k 1.0× 1.7k 1.7× 361 10.7k
Johan L. Severens Netherlands 52 2.4k 0.8× 2.0k 1.1× 976 0.7× 961 0.8× 867 0.8× 259 10.7k
Andrew Lloyd United Kingdom 37 4.3k 1.4× 2.5k 1.4× 1.7k 1.3× 1.4k 1.1× 1.2k 1.1× 175 13.2k
Lieven Annemans Belgium 46 2.3k 0.8× 1.8k 1.0× 1.7k 1.3× 1.7k 1.4× 1.2k 1.1× 440 11.3k
Joel Tsevat United States 51 2.1k 0.7× 2.0k 1.2× 951 0.7× 1.3k 1.1× 1.4k 1.3× 193 9.2k
Dan Greenberg Israel 35 3.4k 1.1× 1.8k 1.1× 1.3k 1.0× 1.4k 1.1× 961 0.9× 242 9.2k
William Hollingworth United Kingdom 53 2.1k 0.7× 1.9k 1.1× 2.8k 2.1× 1.3k 1.1× 1.2k 1.2× 343 11.9k
A. Mark Fendrick United States 53 3.3k 1.1× 2.2k 1.3× 2.5k 1.9× 1.4k 1.2× 956 0.9× 359 11.7k

Countries citing papers authored by Don Husereau

Since Specialization
Citations

This map shows the geographic impact of Don Husereau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Don Husereau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Don Husereau more than expected).

Fields of papers citing papers by Don Husereau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Don Husereau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Don Husereau. The network helps show where Don Husereau may publish in the future.

Co-authorship network of co-authors of Don Husereau

This figure shows the co-authorship network connecting the top 25 collaborators of Don Husereau. A scholar is included among the top collaborators of Don Husereau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Don Husereau. Don Husereau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Breadner, Daniel, David Hwang, Don Husereau, et al.. (2024). Implementation of Liquid Biopsy in Non-Small-Cell Lung Cancer: An Ontario Perspective. Current Oncology. 31(10). 6017–6031. 2 indexed citations
2.
Cella, David, Don Husereau, Bellinda L. King‐Kallimanis, et al.. (2024). Administering selected subscales of patient-reported outcome questionnaires to reduce patient burden and increase relevance: a position statement on a modular approach. Quality of Life Research. 33(4). 1075–1084. 3 indexed citations
3.
Guertin, Jason R., Vakaramoko Diaby, Alice Dragomir, et al.. (2023). French Translation of the 2022 Version of the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement. Canadian Journal of Health Technologies. 3(10).
4.
Catalá-López, Ferrán, Manuel Ridao-López, Lisa Caulley, et al.. (2023). Transparency, openness, and reproducible research practices are frequently underused in health economic evaluations. Journal of Clinical Epidemiology. 165. 111208–111208. 2 indexed citations
5.
Husereau, Don, Yvonne Bombard, Tracy Stockley, et al.. (2023). Future Role of Health Technology Assessment for Genomic Medicine in Oncology: A Canadian Laboratory Perspective. Current Oncology. 30(11). 9660–9669. 3 indexed citations
6.
Mateo, Joaquı́n, Lotte Steuten, Philippe Aftimos, et al.. (2022). Delivering precision oncology to patients with cancer. Nature Medicine. 28(4). 658–665. 197 indexed citations breakdown →
7.
Husereau, Don, Michael Drummond, Federico Augustovski, et al.. (2022). Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force. Value in Health. 25(1). 10–31. 422 indexed citations breakdown →
8.
Husereau, Don, Michael Drummond, Federico Augustovski, et al.. (2022). Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: Updated reporting guidance for health economic evaluations. SHILAP Revista de lepidopterología. 3. 100063–100063. 23 indexed citations
10.
Caulley, Lisa, Wei Cheng, Ferrán Catalá-López, et al.. (2020). Citation impact was highly variable for reporting guidelines of health research: a citation analysis. Journal of Clinical Epidemiology. 127. 96–104. 24 indexed citations
11.
Ezeife, Doreen A., François Dionne, Aline Fusco Fares, et al.. (2019). Value assessment of oncology drugs using a weighted criterion‐based approach. Cancer. 126(7). 1530–1540. 10 indexed citations
12.
Beca, Jaclyn, Don Husereau, Kelvin Chan, Neil Hawkins, & Jeffrey S. Hoch. (2017). Oncology Modeling for Fun and Profit! Key Steps for Busy Analysts in Health Technology Assessment. PharmacoEconomics. 36(1). 7–15. 11 indexed citations
13.
Wodchis, Walter P., et al.. (2016). Using Phase-Based Costing of Real-World Data to Inform Decision–Analytic Models for Atrial Fibrillation. Applied Health Economics and Health Policy. 14(3). 313–322. 5 indexed citations
14.
Kaló, Zoltán, et al.. (2015). Comparison of current and preferred status of hta implementation in central and eastern europen countries. Value in Health. 18(7). A538–A538. 1 indexed citations
15.
Blomqvist, Åke, Colin Busby, & Don Husereau. (2013). Capturing Value from Health Technologies in Lean Times. C.D. Howe Institute Commentary. 4 indexed citations
16.
Husereau, Don, Michael Drummond, Stavros Petrou, et al.. (2013). Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. The European Journal of Health Economics. 14(3). 367–372. 177 indexed citations
17.
Husereau, Don, Michael Drummond, Stavros Petrou, et al.. (2013). Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement. Value in Health. 16(2). e1–e5. 481 indexed citations breakdown →
18.
Mittmann, Nicole, William K. Evans, Angela Rocchi, et al.. (2012). Guidelines for Health Technologies: Specific Guidance for Oncology Products in Canada. Value in Health. 15(3). 580–585. 13 indexed citations
19.
Jetty, Prasad, Don Husereau, Dalibor Kubelik, et al.. (2012). Wait times among patients with symptomatic carotid artery stenosis requiring carotid endarterectomy for stroke prevention. Journal of Vascular Surgery. 56(3). 661–667.e2. 17 indexed citations
20.
Clement, Fiona, Marcello Tonelli, Brenda R. Hemmelgarn, et al.. (2011). Cost-effectiveness of the use of low- and high-potency statins in people at low cardiovascular risk. Canadian Medical Association Journal. 183(16). E1180–E1188. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026